Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
United States
Emory University Hospital Midtown, Atlanta, Georgia Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia Last updated February 2026